Due to Overwhelming Demand, the 5th Annual UK Symposium: Advancing Drug Discovery for Oncology Symposium is Now at Full Capacity

Registrants will typically notify us to prior to the event if they are no longer able to attend. We want you to join us and will notify you as soon as possible when a seat becomes available.

Please complete the form to the right to join the wait list so that if a seat opens up we can let you know! We are requesting your mobile number to allow us to quickly contact you via text message to confirm your seat.

Join the Wait List

Speakers

James Cooke Ph.D. Associate Director, Discovery, Core Phage, Bicycle Therapeutics Talk Title: Bicycles as Precision Guided Therapeutics

Kinmei Leung Ph.D. Director, Translational Sciences, F-Star Therapeutics Talk Title: Next-Generation Tetravalent Bispecific Antibodies for Cancer Therapy

Joana Neves Ph.D. Scientist, Artios Pharma Ltd. Talk Title: Targeting the DNA Polymerase Theta (Polθ) in Cancer Therapy

Roberto Solari Ph.D.  CEO, MYRICX Pharma Ltd Talk Title: Validation of N-Myristolytransferase (NMT) as a Novel and Selective Oncology Target.

Yinfei Yin Ph.D. Executive Director, Head of Scientific Operations, UK & US, Crown Bioscience Talk Title: Adding Value to Drug Development Through In Vivo Imaging

Jelena Urosevic Ph.D. Associate Principal Scientist, AstraZeneca Talk Title: BID Upregulation Shifts Tumor Cells to Apoptosis in Response to AURKB Inhibition

Barbara Cipriani Ph.D. Head of Biology, Pathios Therapeutics  Talk Title: Inhibitors of the pH Sensing GPCR GPR65 Counteract the Immune Suppressive Effects Driven by Acidosis in Macrophages and Suppress Tumour Growth in Syngeneic Models.

Gera Goverse Ph.D. Director Immuno-Oncology, Crown Bioscience Talk Title: Functional Screening with Patient-Derived Organoids Using High Content Imaging